Jian Zhang

Jian Zhang


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 October 2023 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
XLXiandeng Li
Xiandeng Li
YZYing Zhang
Ying Zhang
XXXiaodong Xing
Xiaodong Xing
MLMi Li
Mi Li
YLYan Liu
Yan Liu
JZJian Zhang
Jian Zhang
Diabetic nephropathy (DN) is a severe complication of diabetes mellitus, posing significant challenges in terms of early prevention, clinical diagnosis, and treatment. Consequently, it has emerged as a major contributor to end-stage renal disease. The glomerular filtration barrier, composed of podocytes, endothelial cells, and the glomerular basement membrane, plays a vital role in maintaining renal function. Disruptions in podocyte function, including hypertrophy, shedding, reduced density, and apoptosis, can impair the integrity of the glomerular filtration barrier, resulting in elevated proteinuria, abnormal glomerular filtration rate, and increased creatinine levels. Hence, recent research has increasingly focused on the role of podocyte injury in DN, with a growing emphasis on exploring therapeutic interventions targeting podocyte injury. Studies have revealed that factors such as lipotoxicity, hemodynamic abnormalities, oxidative stress, mitochondrial dysfunction, and impaired autophagy can contribute to podocyte injury. This review aims to summarize the underlying mechanisms of podocyte injury in DN and provide an overview of the current research status regarding experimental drugs targeting podocyte injury in DN. The findings presented herein may offer potential therapeutic targets and strategies for the management of DN associated with podocyte injury.

8 March 2022 in ACS Materials Letters
Verified
Journal Article
Closed access
KWKeming Wu
Keming Wu
CSCongcong Sun
Congcong Sun
ZWZhenni Wang
Zhenni Wang
QSQian Song
Qian Song
XBXiaoxia Bai
Xiaoxia Bai
ZZZhenhuan Zhao
Zhenhuan Zhao

23 September 2020 in ACS Nano
Verified
Journal Article
Closed access
XYXin Yu
Xin Yu
XJXin Jin
Xin Jin
XCXuanyu Chen
Xuanyu Chen
AWAizhu Wang
Aizhu Wang
JZjianming zhang
jianming zhang
Hong LiuHong Liu
Hong Liu

1 April 2021 in Drug Design, Development and Therapy
Verified
Journal Article
Open access
PDF file
XHXiaohui Huang
Xiaohui Huang
ZYZe Yu
Ze Yu
SBShuhong Bu
Shuhong Bu
ZLZhiyan Lin
Zhiyan Lin
XHXin Hao
Xin Hao
JCJihui Chen
Jihui Chen
Purpose: This study aimed to establish an optimal model to predict vancomycin trough concentrations by using machine learning. Patients and Methods: We enrolled 407 pediatric patients (age < 18 years) who received vancomycin intravenously and underwent therapeutic drug monitoring from June 2013 to April 2020 at Xinhua Hospital affiliated to Shanghai Jiaotong University School of Medicine. The median (interquartile range) age and weight of the patients were 2 (0.63– 5) years and 12 (7.8– 19) kg. Vancomycin trough concentrations were considered as the target variable, and eight different algorithms were used for predictive performance comparison. The whole dataset (407 cases) was divided into training group and testing group at the ratio of 80%: 20%, which were 325 and 82 cases, respectively. Results: Ultimately, five algorithms (XGBoost, GBRT, Bagging, ExtraTree and decision tree) with high R 2 (0.657, 0.514, 0.468, 0.425 and 0.450, respectively) were selected and further ensembled to establish the final model and achieve an optimal result. For missing data, through filling the missing values and model ensemble, we obtained R 2=0.614, MAE=3.32, MSE=24.39, RMSE=4.94 and a prediction accuracy of 51.22% (predicted trough concentration within ± 30% of the actual trough concentration). In comparison with the pharmacokinetic models (R 2=0.3), the machine learning model works better in model fitting and has better prediction accuracy. Conclusion: Therefore, the ensemble model is useful for the vancomycin concentration prediction, especially in the population of children with great individual variation. As machine learning methods evolve, the clinical value of the ensemble model will be demonstrated in the clinical practice.

9 April 2021 in Expert Review of Clinical Pharmacology
Verified
Journal Article
Open access
XHXiaohui Huang
Xiaohui Huang
ZYZe Yu
Ze Yu
XWXin Wei
Xin Wei
JSJunfeng Shi
Junfeng Shi
YWYu Wang
Yu Wang
AXAjing Xu
Ajing Xu
Despite therapeutic vancomycin is regularly monitored, its dose requirements vary considerably between individuals. Various innovative vancomycin dosing strategies have been developed for dose opti...

22 August 2024 in ACS Nano
Verified
Journal Article
Closed access
ZYZhongwei Yang
Zhongwei Yang
LWLongwei Wang
Longwei Wang
XZXiaoyu Zhang
Xiaoyu Zhang
JZJian Zhang
Jian Zhang
NRNa Ren
Na Ren
XYXin Yu
Xin Yu